Abstract
The introduction of oxygen atoms into different positions of the vitamin D side chain is described. By combining the arising 23-oxa and 25-oxa elements with other structural modifications (19-nor, iso-19-nor, 20-methyl, 20-ene, 20,21-cyclo) calcitriol analogs with remarkable levels of dissociation between beneficial acitivities on cell growth regulation and undesired hypercalcemia were identified. Structure-activity relations are elaborated in a very systematic outline of the Schering drug finding program in this particular class of vitamin D compounds.
Keywords: Antiproliferative Activities, 23 Oxa Calcitriols, 19 Nor 23 oxa Calcitriols, Iso 19 nor 23 oxa Calcitriols, 20 Methyl 23 oxa calcitriols, 20 Ene 23 oxa Calcitriol, 20 Ene 19 nor 23 oxa Calcitriols, 20 21 Cyclo 23 oxa calcitriols, 25 oxa Calcitriols, Relative binding affinity, Vitamin D receptor, 1 4 Diazabicyclo 2 2 2 octane, Diisobutylaluminum hydride, Vitamin D binding prtien, Human leukemia cell line, Lithium diisopropylamide
Current Pharmaceutical Design
Title: New Synthetic Vitamin D Analogs with Antiproliferative Activities
Volume: 6 Issue: 7
Author(s): Andreas Steinmeyer, Gerald Kirsch, Gunter Neef and Katica Schwarz
Affiliation:
Keywords: Antiproliferative Activities, 23 Oxa Calcitriols, 19 Nor 23 oxa Calcitriols, Iso 19 nor 23 oxa Calcitriols, 20 Methyl 23 oxa calcitriols, 20 Ene 23 oxa Calcitriol, 20 Ene 19 nor 23 oxa Calcitriols, 20 21 Cyclo 23 oxa calcitriols, 25 oxa Calcitriols, Relative binding affinity, Vitamin D receptor, 1 4 Diazabicyclo 2 2 2 octane, Diisobutylaluminum hydride, Vitamin D binding prtien, Human leukemia cell line, Lithium diisopropylamide
Abstract: The introduction of oxygen atoms into different positions of the vitamin D side chain is described. By combining the arising 23-oxa and 25-oxa elements with other structural modifications (19-nor, iso-19-nor, 20-methyl, 20-ene, 20,21-cyclo) calcitriol analogs with remarkable levels of dissociation between beneficial acitivities on cell growth regulation and undesired hypercalcemia were identified. Structure-activity relations are elaborated in a very systematic outline of the Schering drug finding program in this particular class of vitamin D compounds.
Export Options
About this article
Cite this article as:
Steinmeyer Andreas, Kirsch Gerald, Neef Gunter and Schwarz Katica, New Synthetic Vitamin D Analogs with Antiproliferative Activities, Current Pharmaceutical Design 2000; 6 (7) . https://dx.doi.org/10.2174/1381612003400470
DOI https://dx.doi.org/10.2174/1381612003400470 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hibiscus Sabdariffa Linnaeus (Malvaceae), Curcumin and Resveratrol as Alternative Medicinal Agents Against Metabolic Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Anabolic Androgenic Steroids and Intracellular Calcium Signaling: A Mini Review on Mechanisms and Physiological Implications
Mini-Reviews in Medicinal Chemistry Meet Our Editorial Board Member
Current Cancer Therapy Reviews Epigenetics and the Environmental Regulation of the Brain's Genome and its Function
Current Psychiatry Reviews The Pentacyclic Triterpenoids in Herbal Medicines and Their Pharmacological Activities in Diabetes and Diabetic Complications
Current Medicinal Chemistry Telomere Length Variations in Aging and Age-Related Diseases
Current Aging Science miRNA as Regulators of Prostate Carcinogenesis and Endocrine and Chemoresistance
Current Cancer Drug Targets Intracellular Redox Signaling as Therapeutic Target for Novel Antiviral Strategy
Current Pharmaceutical Design Genetics, Structure, Function, Mode of Actions and Role in Cancer Development of CYP17
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Targets for Management of Periodontitis and Diabetes
Current Pharmaceutical Design Critical Aspects to be Considered Prior to Large-Scale Production of Peptides
Current Protein & Peptide Science Network-based Assessment on Chemical-induced Cholestatic Liver Injury
Current Topics in Medicinal Chemistry The Vitamin D Neuroendocrine System as a Target for Novel Neurotropic Drugs
CNS & Neurological Disorders - Drug Targets Extraction, Separation, Detection, and Structural Analysis of Flavonoids
Current Organic Chemistry Bladder Cancer and Stem Cells
Current Signal Transduction Therapy Estrogen Receptor Expression and its Relevant Signaling Pathway in Prostate Cancer: A Target of Therapy
Current Molecular Pharmacology Nanoparticles as Novel Carrier for Brain Delivery: A Review
Current Pharmaceutical Design The Chemical Methods of Disulfide Bond Formation and Their Applications to Drug Conjugates
Current Organic Chemistry Zebrafish as a Model for the Study of the Phase II Cytosolic Sulfotransferases
Current Drug Metabolism 3D-QSAR Modeling of Non-peptide Antagonists for the Human Luteinizing Hormone-releasing Hormone Receptor
Medicinal Chemistry